Stroke Trial, Recruiting NCT06329765 Sponsor: Marquette University Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06329765
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had a single stroke on one side of the brain, occurring in adulthood.
  • People whose stroke affected either the outer layers of the brain (cortex) or the deeper nerve pathways (such as the internal capsule or corona radiata).
  • People who had either a blocked-artery stroke (ischemic) or a bleeding stroke (hemorrhagic).
  • People whose stroke happened more than 6 months ago.
  • People who are able to walk 10 metres, with or without a cane, walker, brace, or other walking aid.
  • People who have weakness on one side of the body as a result of their stroke.
  • People who tend not to use their weaker leg even though some ability to move it remains (confirm with trial site on how this is assessed).
  • People who have no medical reasons preventing them from exercising safely, such as recent heart attack, uncontrolled heart rhythm problems, unstable chest pain, uncontrolled high blood pressure, or severe joint or muscle conditions that would interfere with pedalling.
  • People aged 18 or older.
  • People who are able to commit to 27 visits to the research lab (including assessment sessions and 24 training sessions).

Who may not be able to join:

  • People who have had more than one stroke that caused lasting effects or showed up on brain imaging (note: a mini-stroke, or TIA, that left no lasting damage does not automatically exclude someone).
  • People whose stroke primarily affected the cerebellum (the part of the brain that coordinates balance and movement) or the basal ganglia (areas deep in the brain involved in movement control).
  • People with dementia or other cognitive difficulties that interfere with learning or with giving informed consent.
  • People with communication difficulties, such as trouble understanding spoken or written language, that would prevent safe participation (note: people who have difficulty speaking but can communicate in another way are not automatically excluded).
  • People with joint, muscle, or bone problems that would interfere with pedalling.
  • People with heart or cardiovascular conditions that make exercise unsafe.
  • People who are unable to walk 10 metres overground, or cannot do so safely.
  • People with any other neurological condition or brain injury besides stroke, such as cerebral palsy, epilepsy, Parkinson's disease, multiple sclerosis, brain tumour, head trauma, or diabetic nerve damage.
  • People with any other condition that the research team determines could make participation unsafe or could affect the study results.
  • People who do not meet all of the inclusion criteria listed above.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Marquette University
Registry
ClinicalTrials.gov
Start date
7 August 2023
Est. completion
4 April 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Paretic limb use in walking; Paretic limb use in pedaling; Interlimb coordination in walking; Interlimb coordination in pedaling; Motorized intervention during pedaling split-crank (i.e., bilateral uncoupled) pedaling; Absences; Adverse events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov